IP Library Granted Patent US 8,574,185
Granted Patent B2
US 8,574,185 · App. 13/101,240 · Granted Nov 5, 2013

Implantable arterio-venous shunt devices and methods for their use

Inventors: John Faul (San Clemente, CA); Toshihiko Nishimura (San Clemente, CA); Peter Kao (San Clemente, CA); Ronald Pearl (San Clemente, CA)
Assignee: The Board Trustees of the Leland Stanford Junior University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,574,185
App. No.
13/101,240
Granted
Nov 5, 2013
Kind
B2
Abstract

A long-term implantable arterio-venous shunt device or creation of a fistula is provided that can be used as a therapeutic method for treating chronic obstructive pulmonary disease (COPD). The shunt device is implanted between an artery and a vein, preferably between a peripheral artery and the inferior vena cava. The shunt device and method of creating a fistula increases cardiac output and decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. Based on the effects of the method and device to the respiratory, cardiac and circulatory system, the method and device are beneficial as a therapy to patients with problems or conditions related to these systems.

Claims (9)

1. A therapeutic method for increasing cardiac output in a human subject, the method comprising:

selecting a patient suffering from a disease selected from the group consisting of: congestive heart failure, coronary artery disease, lung fibrosis, emphysema, cystic fibrosis, and cystic lung disease, and

creating a fistula between a peripheral artery and a peripheral vein of said subject, said fistula adapted to allow a blood flow rate therethrough of at least 5 ml/min, wherein said blood flow through the fistula bypasses the peripheral microcirculation, and wherein creation of said fistula results in an increase in the cardiac output, a decrease in mean arterial blood pressure, and decreased systemic vascular resistance in said subject.

2. The method as set forth in claim 1 , wherein the fistula forms a lumen between the artery and the vein, the lumen having a length between 2.5 mm and 15 mm.

3. The method of claim 2 , wherein the artery and the vein are both of the same type and are selected from the group consisting of: an iliac artery and an iliac vein, and a femoral artery and a femoral vein.

4. The method of claim 2 , wherein the artery is either the iliac artery or the femoral artery, and the vein is either the iliac vein or the femoral vein.

5. The method of claim 2 , wherein the artery and the vein are both of the same type and are selected from the group consisting of: an auxiliary artery and an auxiliary vein, and a subclavian artery and a subclavian vein.

6. The method as set forth in claim 2 , wherein the method lowers mean arterial blood pressure of the subject by at least 5%.

7. The method as set forth in claim 2 , wherein the fistula is created via an open surgical procedure, a minimally invasive surgical procedure, or an intravascular procedure.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2016
From: PEARL, RONALD G.; FAUL, JOHN L.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 038682/0156 →
Continuity (6)
Continuation 11789759 · Apr 24, 2007
Continuation In Part 10961731 · Oct 7, 2004
Continuation In Part 10820169 · Apr 6, 2004
Provisional Application 60461467 · Apr 8, 2003
Provisional Application 60923502 · Apr 13, 2007
Related Publication 20110270149A1 · Nov 3, 2011